GPhC registered|Tracked Delivery
Wegovy Tablets (Semaglutide (oral))
Active ingredient
Semaglutide
Formulation
Oral tablet (once daily)
Class
GLP-1 receptor agonist
Manufacturer
Novo Nordisk
“Every Wegovy Tablets prescription is reviewed personally. We check suitability, interactions, and whether it is the right clinical choice.”
— Younes Mekhalfia, GPhC-registered pharmacist

Wegovy Tablets

Semaglutide (oral)

The first oral GLP-1 tablet licensed for weight management in the UK (MHRA approved June 2026), used as part of a UK pharmacist-led weight management programme, prescribed after clinical review.

£85/ month

1.5mg · Starter · Subscribe & Save · £105 without subscription

Final pricing confirmed at assessment.

Select strength

Your prescriber confirms your Wegovy Tablets dose at assessment.

  • Once-daily tablet — no needles
  • GLP-1 hormone action
  • No fridge or cold-chain needed — store at room temperature
  • Refill request reviewed before every supply
Check eligibility

Free consultation · You’re only charged if treatment is approved

  • GPhC-registered pharmacy
  • UK Licensed Medication
  • Discreet packaging

Transparent pricing

Dose Pricing

Prices are shown per month. Subscribe & Save reduces the monthly cost while keeping every treatment decision under prescriber review.

No automatic dose changes
StrengthFlexibleSubscribe & Save
1.5mg£105£85
4mg£109£89
9mg£125£105
25mg£180£160

Dose changes only proceed after prescriber review of your progress, tolerance, side effects, and updated clinical information. Your treatment plan proceeds only when clinically approved.

How it works

How Wegovy Tablets works in the body

  1. Regulates appetite

    Semaglutide mimics GLP-1, a natural gut hormone that signals fullness to the brain — reducing hunger and cravings throughout the day.

  2. Slows gastric emptying

    Food remains in the stomach longer, so smaller portions feel more satisfying and blood sugar rises more slowly after meals.

  3. Same active ingredient, no needles

    It contains the same active ingredient as the Wegovy injection, formulated so it can be absorbed from the stomach — taken once daily on an empty stomach instead of injected weekly.

Clinical evidence

What the trial data shows

Peer-reviewed evidence for Wegovy Tablets, cited and attributed — not reframed as a personal promise.

Randomised controlled trial

OASIS-4

OASIS-4 investigators, NEJM 2025

Participants
307
Duration
64 weeks
Comparator
vs. placebo, alongside lifestyle intervention

Participants taking oral semaglutide 25 mg once daily lost up to ~16.6% of baseline body weight over 64 weeks versus ~2.7% on placebo in clinical-trial analyses (more conservative analysis methods estimated ~13.6%). Trial participants had BMI ≥ 30, or ≥ 27 with a weight-related comorbidity.

Trial results do not predict individual outcomes. Your pharmacist will discuss realistic expectations during consultation.

Dosing

Typical dosing schedule

Doses escalate gradually under pharmacist supervision to support tolerability. Your exact plan is set during your consultation.

Typical Wegovy Tablets dose escalation schedule
WeekNotes
Weeks 1–4

1.5 mg

Starter dose — primarily for tolerance

Weeks 5–8

4 mg

Second escalation step

Weeks 9–12

9 mg

Third escalation step

Weeks 13+

25 mg

Maintenance dose — the strength studied in OASIS. Each step lasts a minimum of one month

Safety profile

Possible side effects

Grouped by frequency. Your pharmacist will review these with you in detail before you start.

Common
  • Nausea (most common during dose escalation)
  • Diarrhoea
  • Constipation
  • Vomiting
  • Reduced appetite / early satiety
  • Indigestion or heartburn
Uncommon
  • Abdominal pain
  • Fatigue or dizziness
  • Gallbladder disease
  • Hair thinning (associated with rapid weight loss, not the drug itself)
Rare
  • Acute pancreatitis — seek urgent medical advice for severe abdominal pain
  • Severe allergic reaction
  • Hypoglycaemia (mainly if combined with insulin or sulfonylureas)

Not a complete list. Read the Patient Information Leaflet supplied with your medication. Report any suspected side effects to the MHRA Yellow Card scheme.

Eligibility

Is Wegovy Tablets right for you?

Usually suitable for

  • Adults (18+) with BMI ≥ 30, or ≥ 27 with a weight-related condition
  • Patients who have attempted lifestyle-led weight management without sustained effect
  • Patients able to take a daily tablet on an empty stomach and wait 30 minutes before eating, drinking, or taking other oral medicines
  • Patients who can attend follow-up pharmacist reviews as part of the programme

Not suitable if you are / have

  • Pregnancy, planning pregnancy, or breastfeeding
  • Personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 syndrome
  • Active severe gastrointestinal disease (e.g. gastroparesis, severe IBD)
  • History of acute pancreatitis
  • Type 1 diabetes (off-label for weight management)
  • Age under 18 years

This is a summary, not a complete assessment. A pharmacist reviews your full health history during consultation before any prescription is issued.

What’s included

Everything in your welcome kit

  • 01Wegovy Tablets 30-tablet blister pack (one month supply)
  • 02How-to-take guide covering the empty-stomach and 30-minute rules
  • 03Standard tracked delivery — no cold-chain packaging needed
  • 04Monthly pharmacist check-ins as part of the weight-loss programme
  • 05Direct pharmacist chat through your dashboard
Younes Mekhalfia - independent prescribing pharmacist
Independent Prescribing Pharmacist

Dispensed & Checked by Us

Unlike other online services, we don’t outsource your care. Every prescription is reviewed, dispensed, and packed by our UK-based clinical team. You’re not just a number - you’re a patient we’re committed to supporting.

“Each consultation is reviewed by a qualified prescriber within their clinical scope before any prescription treatment is supplied.”

— Younes Mekhalfia, Independent Prescribing Pharmacist

Every order

Clinical Review

In-house

UK Dispensing

Individual

Clinical Support

Real humans

Support

Everything you need to know about Wegovy Tablets

Find answers about treatment, safety and the service journey.

What are Wegovy Tablets?

Wegovy Tablets are a once-daily oral form of semaglutide, approved by the MHRA in June 2026 as the first oral GLP-1 treatment licensed for weight management in the UK. It contains the same active ingredient as the Wegovy injection, in a tablet you swallow instead of a weekly injection.

Is it the same medicine as the Wegovy injection?

It contains the same active ingredient — semaglutide, a GLP-1 receptor agonist. The difference is the formulation and schedule: the tablet is taken once daily on an empty stomach, while the injection is taken once weekly. Your pharmacist can discuss which form suits your routine and clinical context.

How do the tablets work?

They mimic the hormone GLP-1, which regulates appetite. It signals your brain that you are full and slows down stomach emptying, so you feel satisfied with less food and experience fewer cravings — the same mechanism as injectable semaglutide.

What does the clinical trial data show?

In the OASIS clinical trial programme, participants taking oral semaglutide 25mg once daily lost up to around 15–17% of baseline body weight over 64 weeks versus roughly 3% on placebo, depending on the analysis used. Trial results do not predict individual outcomes — your pharmacist will discuss realistic expectations as part of your consultation, taking into account your starting weight, health profile, and lifestyle.

Is oral semaglutide proven safe?

Semaglutide itself has been used for over a decade (originally for diabetes) and has extensive long-term safety data, and a lower-dose oral form has been prescribed for type 2 diabetes since 2020. The weight-management tablet was assessed by the MHRA against the OASIS trial data before its 2026 approval.

Why choose the tablet over the injection?

Many patients simply prefer not to inject: there are no needles, no sharps bin, and no fridge storage. The trade-off is a stricter daily routine — the tablet must be taken on an empty stomach with a 30-minute wait before food. The injection remains a good fit for patients who prefer a once-weekly schedule.

Can I take Wegovy Tablets if I don't have diabetes?

Yes. Wegovy Tablets are specifically licensed for weight management in people without diabetes who have a BMI over 30 (or 27 with weight-related health conditions like high blood pressure).

How do I take Wegovy Tablets?

Take one tablet when you wake up, on an empty stomach after your overnight fast. Swallow it whole with a small sip of water (up to about 120ml), then wait at least 30 minutes before eating, drinking anything else, or taking other oral medicines. This routine matters — it is how the medicine is absorbed properly.

Why does it have to be on an empty stomach?

Semaglutide is a fragile molecule to absorb through the stomach. Food, drink, or other medicines taken too close to your tablet significantly reduce how much is absorbed, which can make the treatment less effective. Taking it first thing after waking, then waiting 30 minutes, gives you the intended dose.

What are the dosage steps?

1.5mg (Month 1), 4mg (Month 2), 9mg (Month 3), and 25mg (Maintenance). Each step lasts a minimum of one month. This gradual increase helps minimise side effects while your body adjusts.

What if I forget to take it?

Skip the missed dose and take your next tablet the following morning as normal. Never take two tablets on the same day to catch up.

Can I crush or split the tablet?

No. The tablet must be swallowed whole — crushing, splitting, or chewing it disrupts the way the medicine is absorbed and can make it ineffective.

Do I have to increase the dose every month?

Each titration step lasts at least one month, but you can stay on a step for longer. If your pharmacist is satisfied with your clinical response and you are experiencing side effects, the escalation can be paused or slowed. Finding a well-tolerated dose matters more than following a rigid schedule.

Can I switch from the Wegovy injection to the tablets?

Yes. Patients established on the 2.4mg weekly injection can switch directly to the 25mg daily tablet without re-titrating from the starting dose. Your pharmacist will confirm the switch and the timing of your first tablet as part of your review.

Can I take my other morning medicines at the same time?

No — take other oral medicines at least 30 minutes after your Wegovy tablet, as they can interfere with its absorption. If you take medicines with strict timing requirements (such as levothyroxine), mention this in your consultation so your pharmacist can help you plan a routine.

Still have questions? Our pharmacist team is here to help.

Contact us

Your health shouldn’t wait.

Free consultation, pharmacist-reviewed, discreet delivery.

Start your consultation